Physician profile
Matthew Acton
NPI 1578732772
$399.33
in general payments reported to CMS, 2019-2025
9 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.91 · 2021: $63.89 · 2023: $22.79 · 2024: $142 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221 · Education: $96.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.03 |
| Education | $96.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $96.50 | 2025 | |
| Edwards Lifesciences Corporation | $93.38 | 2024 | Konect Resilia |
| Pfizer INC. | $44.76 | 2021 | |
| Gilead Sciences, INC. | $41.54 | 2023-2025 | Veklury |
| Integra Lifesciences Corporation | $36.34 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Avita Medical Americas, LLC | $24.49 | 2024 | |
| Abbott Laboratories | $24.26 | 2024 | Freestyle Libre 3 |
| Polynovo North America LLC | $20.15 | 2025 | Novosorb Btm |
| Kci USA, INC. | $17.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Acton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.